APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 62 filers reported holding APTOSE BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $154,000 | -65.2% | 70,563 | -46.9% | 0.08% | -69.2% |
Q2 2021 | $442,000 | -50.7% | 133,000 | -11.3% | 0.28% | -62.4% |
Q1 2021 | $896,000 | -75.2% | 150,000 | -81.8% | 0.73% | -56.0% |
Q4 2020 | $3,613,000 | -47.1% | 824,795 | -27.6% | 1.67% | -48.7% |
Q3 2020 | $6,835,000 | +38.3% | 1,139,094 | +45.5% | 3.25% | +53.3% |
Q2 2020 | $4,941,000 | – | 783,073 | – | 2.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 690,000 | $4,123,000 | 3.63% |
DRW Securities, LLC | 7,976,176 | $47,658,000 | 1.89% |
Ally Bridge Group (NY) LLC | 1,409,150 | $8,420,000 | 1.61% |
Nantahala Capital Management | 7,738,892 | $46,240,000 | 1.35% |
PRECEPT MANAGEMENT LLC | 330,766 | $1,976,000 | 1.35% |
First Light Asset Management, LLC | 3,102,788 | $18,539,000 | 1.23% |
Voss Capital, LLC | 440,000 | $2,629,000 | 1.10% |
VR Adviser, LLC | 1,605,400 | $9,592,000 | 1.04% |
Endurant Capital Management LP | 517,472 | $3,092,000 | 0.81% |
Opaleye Management Inc. | 871,800 | $5,209,000 | 0.76% |